-
Electronic (PDF)
-
Site License
-
Enterprisewide
Nerviano Medical Sciences S.r.l. - Product Pipeline Review - Q2 2011
Global Markets Direct, July 2011, Pages: 26
Nerviano Medical Sciences S.r.l. – Product Pipeline Review – Q2 2011
Summary
Global Market Direct’s pharmaceuticals report, “Nerviano Medical Sciences S.r.l. - Product Pipeline Review - Q2 2011” provides data on the Nerviano Medical Sciences S.r.l.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Nerviano Medical Sciences S.r.l.’s corporate website, SEC filings, investor presentations and featured press releases, both from Nerviano Medical Sciences S.r.l. and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Nerviano Medical Sciences S.r.l. - Brief Nerviano Medical Sciences S.r.l. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Nerviano Medical Sciences S.r.l. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Nerviano Medical Sciences S.r.l. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Nerviano Medical Sciences S.r.l.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Nerviano Medical Sciences S.r.l.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Nerviano Medical Sciences S.r.l. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Nerviano Medical Sciences S.r.l.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Nerviano Medical Sciences S.r.l..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Nerviano Medical Sciences S.r.l. and identify potential opportunities in those areas.
List of Tables
List of Figures
Nerviano Medical Sciences S.r.l. Snapshot
Nerviano Medical Sciences S.r.l. Overview
Key Information
Key Facts
Nerviano Medical Sciences S.r.l. – Research and Development Overview
Key Therapeutic Areas
Nerviano Medical Sciences S.r.l. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Nerviano Medical Sciences S.r.l. – Pipeline Products Glance
Nerviano Medical Sciences S.r.l. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Nerviano Medical Sciences S.r.l. – Drug Profiles
Nemorubicin
Product Description
Mechanism of Action
R&D Progress
Nerviano Medical Sciences S.r.l. - Pipeline Products By Target
Nerviano Medical Sciences S.r.l. – Pipeline Products by Route of Administration
Nerviano Medical Sciences S.r.l. – Pipeline Products by Molecule Type
Nerviano Medical Sciences S.r.l. – Locations And Subsidiaries
Head Office
Financial Deals Landscape
Nerviano Medical Sciences S.r.l., Deals Volume Summary, 2004 to YTD 2011
Nerviano Medical Sciences S.r.l., Deals Summary By Region, 2004 to YTD 2011
Nerviano Medical Sciences S.r.l., Deals Summary, 2004 to YTD 2011
Nerviano Medical Sciences S.r.l. Detailed Deal Summary
Nerviano Medical Sciences Enters Into Collaboration With Genentech
Nerviano Medical Sciences Enters Into Collaboration With Genentech
Indena Enters Into Co-Development Agreement With Nerviano Medical Sciences
ChemDiv Extends Co-Development Agreement With Nerviano Medical Sciences
Nerviano Medical Enters Into Co-Development Agreement With Bristol-Myers
Licensing Agreements
Nerviano Medical Enters Into Licensing Agreement With Systems Medicine
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Nerviano Medical Sciences S.r.l. – Pipeline by Therapy Area and Indication, 2011
Nerviano Medical Sciences S.r.l. – Pipeline by Stage of Development, 2011
Nerviano Medical Sciences S.r.l. – Monotherapy Products in Pipeline, 2011
Nerviano Medical Sciences S.r.l. - Phase II, 2011
Nerviano Medical Sciences S.r.l. - Pipeline By Target, 2011
Nerviano Medical Sciences S.r.l. – Pipeline By Route of Administration, 2011
Nerviano Medical Sciences S.r.l. – Pipeline By Molecule Type, 2011
Nerviano Medical Sciences S.r.l., Deals Summary, 2004 to YTD 2011
Nerviano Medical Sciences S.r.l., Deals Summary by Region, 2004 to YTD 2011
Nerviano Medical Sciences S.r.l., Deals Summary, 2004 to YTD 2011
List of Figures
Nerviano Medical Sciences S.r.l. – Pipeline by Therapy Area and Indication, 2011
Nerviano Medical Sciences S.r.l. – Pipeline by Stage of Development, 2011
Nerviano Medical Sciences S.r.l. – Monotherapy Products in Pipeline, 2011
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
